English
简体中文
Total: £ 56.28
Published Date: 2025-04-01 | Pages: 73 | Tables: 79 | Medical Devices & Consumables
The global market for Angiogenesis Assay was valued at US$ 20.9 million in the year 2024 and is projected to reach a revised size of US$ 35.1 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.
This report aims to provide a comprehensive presentation of the global market for Angiogenesis Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiogenesis Assay.
The Angiogenesis Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Angiogenesis Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiogenesis Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Bio-Techne
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray
Segment by Type
In Vitro Assay Kit
In Vivo Assay Kit
Segment by Application
Academic Institution
Biotech Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angiogenesis Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiogenesis Assay Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vitro Assay Kit
1.2.3 In Vivo Assay Kit
1.3 Market by Application
1.3.1 Global Angiogenesis Assay Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic Institution
1.3.3 Biotech Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiogenesis Assay Market Perspective (2020-2031)
2.2 Global Angiogenesis Assay Growth Trends by Region
2.2.1 Global Angiogenesis Assay Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Angiogenesis Assay Historic Market Size by Region (2020-2025)
2.2.3 Angiogenesis Assay Forecasted Market Size by Region (2026-2031)
2.3 Angiogenesis Assay Market Dynamics
2.3.1 Angiogenesis Assay Industry Trends
2.3.2 Angiogenesis Assay Market Drivers
2.3.3 Angiogenesis Assay Market Challenges
2.3.4 Angiogenesis Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angiogenesis Assay Players by Revenue
3.1.1 Global Top Angiogenesis Assay Players by Revenue (2020-2025)
3.1.2 Global Angiogenesis Assay Revenue Market Share by Players (2020-2025)
3.2 Global Angiogenesis Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Angiogenesis Assay Revenue
3.4 Global Angiogenesis Assay Market Concentration Ratio
3.4.1 Global Angiogenesis Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiogenesis Assay Revenue in 2024
3.5 Global Key Players of Angiogenesis Assay Head office and Area Served
3.6 Global Key Players of Angiogenesis Assay, Product and Application
3.7 Global Key Players of Angiogenesis Assay, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Angiogenesis Assay Breakdown Data by Type
4.1 Global Angiogenesis Assay Historic Market Size by Type (2020-2025)
4.2 Global Angiogenesis Assay Forecasted Market Size by Type (2026-2031)
5 Angiogenesis Assay Breakdown Data by Application
5.1 Global Angiogenesis Assay Historic Market Size by Application (2020-2025)
5.2 Global Angiogenesis Assay Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Angiogenesis Assay Market Size (2020-2031)
6.2 North America Angiogenesis Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Angiogenesis Assay Market Size by Country (2020-2025)
6.4 North America Angiogenesis Assay Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angiogenesis Assay Market Size (2020-2031)
7.2 Europe Angiogenesis Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Angiogenesis Assay Market Size by Country (2020-2025)
7.4 Europe Angiogenesis Assay Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angiogenesis Assay Market Size (2020-2031)
8.2 Asia-Pacific Angiogenesis Assay Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Angiogenesis Assay Market Size by Region (2020-2025)
8.4 Asia-Pacific Angiogenesis Assay Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angiogenesis Assay Market Size (2020-2031)
9.2 Latin America Angiogenesis Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Angiogenesis Assay Market Size by Country (2020-2025)
9.4 Latin America Angiogenesis Assay Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angiogenesis Assay Market Size (2020-2031)
10.2 Middle East & Africa Angiogenesis Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Angiogenesis Assay Market Size by Country (2020-2025)
10.4 Middle East & Africa Angiogenesis Assay Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Angiogenesis Assay Introduction
11.1.4 Abcam Revenue in Angiogenesis Assay Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Angiogenesis Assay Introduction
11.2.4 Bio-Techne Revenue in Angiogenesis Assay Business (2020-2025)
11.2.5 Bio-Techne Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Angiogenesis Assay Introduction
11.3.4 Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Cell Biolabs, Inc.
11.4.1 Cell Biolabs, Inc. Company Details
11.4.2 Cell Biolabs, Inc. Business Overview
11.4.3 Cell Biolabs, Inc. Angiogenesis Assay Introduction
11.4.4 Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (2020-2025)
11.4.5 Cell Biolabs, Inc. Recent Development
11.5 BioVision, Inc
11.5.1 BioVision, Inc Company Details
11.5.2 BioVision, Inc Business Overview
11.5.3 BioVision, Inc Angiogenesis Assay Introduction
11.5.4 BioVision, Inc Revenue in Angiogenesis Assay Business (2020-2025)
11.5.5 BioVision, Inc Recent Development
11.6 PromoCell GmbH
11.6.1 PromoCell GmbH Company Details
11.6.2 PromoCell GmbH Business Overview
11.6.3 PromoCell GmbH Angiogenesis Assay Introduction
11.6.4 PromoCell GmbH Revenue in Angiogenesis Assay Business (2020-2025)
11.6.5 PromoCell GmbH Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA Angiogenesis Assay Introduction
11.7.4 Merck KGaA Revenue in Angiogenesis Assay Business (2020-2025)
11.7.5 Merck KGaA Recent Development
11.8 Kollodis BioSciences
11.8.1 Kollodis BioSciences Company Details
11.8.2 Kollodis BioSciences Business Overview
11.8.3 Kollodis BioSciences Angiogenesis Assay Introduction
11.8.4 Kollodis BioSciences Revenue in Angiogenesis Assay Business (2020-2025)
11.8.5 Kollodis BioSciences Recent Development
11.9 Sartorius (Essen BioScience)
11.9.1 Sartorius (Essen BioScience) Company Details
11.9.2 Sartorius (Essen BioScience) Business Overview
11.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Introduction
11.9.4 Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (2020-2025)
11.9.5 Sartorius (Essen BioScience) Recent Development
11.10 Creative Bioarray
11.10.1 Creative Bioarray Company Details
11.10.2 Creative Bioarray Business Overview
11.10.3 Creative Bioarray Angiogenesis Assay Introduction
11.10.4 Creative Bioarray Revenue in Angiogenesis Assay Business (2020-2025)
11.10.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Angiogenesis Assay Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vitro Assay Kit
Table 3. Key Players of In Vivo Assay Kit
Table 4. Global Angiogenesis Assay Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Angiogenesis Assay Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Angiogenesis Assay Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Angiogenesis Assay Market Share by Region (2020-2025)
Table 8. Global Angiogenesis Assay Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Angiogenesis Assay Market Share by Region (2026-2031)
Table 10. Angiogenesis Assay Market Trends
Table 11. Angiogenesis Assay Market Drivers
Table 12. Angiogenesis Assay Market Challenges
Table 13. Angiogenesis Assay Market Restraints
Table 14. Global Angiogenesis Assay Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Angiogenesis Assay Market Share by Players (2020-2025)
Table 16. Global Top Angiogenesis Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Assay as of 2024)
Table 17. Ranking of Global Top Angiogenesis Assay Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Angiogenesis Assay Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Angiogenesis Assay, Headquarters and Area Served
Table 20. Global Key Players of Angiogenesis Assay, Product and Application
Table 21. Global Key Players of Angiogenesis Assay, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Angiogenesis Assay Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Angiogenesis Assay Revenue Market Share by Type (2020-2025)
Table 25. Global Angiogenesis Assay Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Angiogenesis Assay Revenue Market Share by Type (2026-2031)
Table 27. Global Angiogenesis Assay Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Angiogenesis Assay Revenue Market Share by Application (2020-2025)
Table 29. Global Angiogenesis Assay Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Angiogenesis Assay Revenue Market Share by Application (2026-2031)
Table 31. North America Angiogenesis Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Angiogenesis Assay Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Angiogenesis Assay Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Angiogenesis Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Angiogenesis Assay Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Angiogenesis Assay Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Angiogenesis Assay Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Angiogenesis Assay Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Angiogenesis Assay Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Angiogenesis Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Angiogenesis Assay Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Angiogenesis Assay Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Angiogenesis Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Angiogenesis Assay Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Angiogenesis Assay Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abcam Company Details
Table 47. Abcam Business Overview
Table 48. Abcam Angiogenesis Assay Product
Table 49. Abcam Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 50. Abcam Recent Development
Table 51. Bio-Techne Company Details
Table 52. Bio-Techne Business Overview
Table 53. Bio-Techne Angiogenesis Assay Product
Table 54. Bio-Techne Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 55. Bio-Techne Recent Development
Table 56. Thermo Fisher Scientific Company Details
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Angiogenesis Assay Product
Table 59. Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Cell Biolabs, Inc. Company Details
Table 62. Cell Biolabs, Inc. Business Overview
Table 63. Cell Biolabs, Inc. Angiogenesis Assay Product
Table 64. Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 65. Cell Biolabs, Inc. Recent Development
Table 66. BioVision, Inc Company Details
Table 67. BioVision, Inc Business Overview
Table 68. BioVision, Inc Angiogenesis Assay Product
Table 69. BioVision, Inc Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 70. BioVision, Inc Recent Development
Table 71. PromoCell GmbH Company Details
Table 72. PromoCell GmbH Business Overview
Table 73. PromoCell GmbH Angiogenesis Assay Product
Table 74. PromoCell GmbH Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 75. PromoCell GmbH Recent Development
Table 76. Merck KGaA Company Details
Table 77. Merck KGaA Business Overview
Table 78. Merck KGaA Angiogenesis Assay Product
Table 79. Merck KGaA Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 80. Merck KGaA Recent Development
Table 81. Kollodis BioSciences Company Details
Table 82. Kollodis BioSciences Business Overview
Table 83. Kollodis BioSciences Angiogenesis Assay Product
Table 84. Kollodis BioSciences Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 85. Kollodis BioSciences Recent Development
Table 86. Sartorius (Essen BioScience) Company Details
Table 87. Sartorius (Essen BioScience) Business Overview
Table 88. Sartorius (Essen BioScience) Angiogenesis Assay Product
Table 89. Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 90. Sartorius (Essen BioScience) Recent Development
Table 91. Creative Bioarray Company Details
Table 92. Creative Bioarray Business Overview
Table 93. Creative Bioarray Angiogenesis Assay Product
Table 94. Creative Bioarray Revenue in Angiogenesis Assay Business (2020-2025) & (US$ Million)
Table 95. Creative Bioarray Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Angiogenesis Assay Picture
Figure 2. Global Angiogenesis Assay Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Angiogenesis Assay Market Share by Type: 2024 VS 2031
Figure 4. In Vitro Assay Kit Features
Figure 5. In Vivo Assay Kit Features
Figure 6. Global Angiogenesis Assay Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Angiogenesis Assay Market Share by Application: 2024 VS 2031
Figure 8. Academic Institution Case Studies
Figure 9. Biotech Companies Case Studies
Figure 10. Angiogenesis Assay Report Years Considered
Figure 11. Global Angiogenesis Assay Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Angiogenesis Assay Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Angiogenesis Assay Market Share by Region: 2024 VS 2031
Figure 14. Global Angiogenesis Assay Market Share by Players in 2024
Figure 15. Global Top Angiogenesis Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Assay as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Angiogenesis Assay Revenue in 2024
Figure 17. North America Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Angiogenesis Assay Market Share by Country (2020-2031)
Figure 19. United States Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Angiogenesis Assay Market Share by Country (2020-2031)
Figure 23. Germany Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Angiogenesis Assay Market Share by Region (2020-2031)
Figure 31. China Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Angiogenesis Assay Market Share by Country (2020-2031)
Figure 39. Mexico Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Angiogenesis Assay Market Share by Country (2020-2031)
Figure 43. Turkey Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Angiogenesis Assay Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Abcam Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 47. Bio-Techne Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 49. Cell Biolabs, Inc. Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 50. BioVision, Inc Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 51. PromoCell GmbH Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 52. Merck KGaA Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 53. Kollodis BioSciences Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 54. Sartorius (Essen BioScience) Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 55. Creative Bioarray Revenue Growth Rate in Angiogenesis Assay Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
